Aims/hypothesis Women who develop gestational diabetes mellitus (GDM) have an elevated
lifetime risk of type 2 diabetes mellitus. Recently, a series of studies has suggested that …

Background: Recent interest has focused on a unique subgroup of overweight and obese
individuals who have normal metabolic features despite increased adiposity. Normal-weight …

Not all patients with type 2 diabetes develop renal dysfunction. Identifying those at risk is
problematic because even microalbuminuria, often used clinically as an indicator of future renal …

Acute-phase biomarkers such as C-reactive protein (CRP) and IL-6 have emerged as
predictors of incident type 2 diabetes mellitus, implicating chronic subclinical inflammation as a …

The utility of the disposition index as a measure of β‐cell compensatory capacity rests on the
established hyperbolic relationship between its component insulin secretion and sensitivity …

OBJECTIVE—To determine whether women with gestational diabetes mellitus (GDM) have
an increased risk of cardiovascular disease (CVD) following pregnancy. RESEARCH …

OBJECTIVE Women who have gestational diabetes mellitus (GDM) have elevated lifetime
risks for the development of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD…

Background Combination treatment with a glucagon-like peptide-1 (GLP-1) agonist and basal
insulin has been proposed as a treatment strategy for type 2 diabetes that could provide …

OBJECTIVE Clinical studies evaluating the effects of medications on β-cell function in type 2
diabetes (T2DM) are compromised by an inability to determine the actual baseline degree …

OBJECTIVE To examine cross-sectional associations of serum vitamin D [25-hydroxyvitamin
D, 25(OH)D] concentration with insulin resistance (IR) and β-cell dysfunction in 712 …